diabetes patients

GLP-1 medications such as Ozempic and Wegovy, originally developed for diabetes and now widely used for weight loss, are showing effects that reach beyond the scale. A report from The Atlantic examines growing evidence and debate that these drugs may also influence mental health, with patients and clinicians reporting changes in mood, appetite, and behavior, even as questions remain about long-term psychological effects.

The American Diabetes Association has released new guidance aimed at helping primary care providers use diabetes technology, such as continuous glucose monitors and insulin delivery systems, in everyday patient care. The move reflects how these tools are shifting from specialist settings into general practice, and clinicians are expected to review the recommendations for managing patients with diabetes.